Revascularization Results in Nonagenarian Patients With Critical Lower Limb Ischaemia
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Critical Limb Ischemia
- Sponsor
- Hospital Universitario Getafe
- Enrollment
- 53
- Primary Endpoint
- Incidence at 30 days of major adverse cardiovascular events (MACE)
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The rise in life expectancy implies an increased number of nonagenarian patients who need evaluation for critical lower limb ischaemia (CLI). The study goal is to evaluate whether revascularization techniques in these patients fulfill a set of security and efficacy criteria generated from surgical results in a validated historical cohort.
Investigators
Joaquin de Haro, M.D.
Joaquin de Haro, M.D.
Hospital Universitario Getafe
Eligibility Criteria
Inclusion Criteria
- •Patients suffering from Critical Limb Ischemia aged 90 year-old or above
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Incidence at 30 days of major adverse cardiovascular events (MACE)
Time Frame: 30 days after the procedure
Incidence at 30 days of major adverse cardiovascular events (MACE): stroke, myocardial infarction or death by cardiovascular cause, in percentage.
Incidence at 30 days of major adverse limb events (MALE)
Time Frame: 30 days after the procedure
Incidence at 30 days of major adverse limb events (MALE): limb acute ischemia or amputation, in percentage.
Incidence at 30 days of limb major amputations (MA)
Time Frame: 30 days after the procedure
Incidence at 30 days of limb major amputations (MA), in percentage.
Secondary Outcomes
- Limb salvage (LS)(12 months after the procedure)
- Survival(12 months after the procedure)